BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 26579534)

  • 1. The estrogenic effect of trigonelline and 3,3-diindolymethane on cell growth in non-malignant colonocytes.
    Yoo G; Allred CD
    Food Chem Toxicol; 2016 Jan; 87():23-30. PubMed ID: 26593444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach.
    Lowe L; LaValley JW; Felsher DW
    Cancer Drug Resist; 2022; 5(4):917-925. PubMed ID: 36627896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis.
    Wang W; Niu S; Qiao L; Wei F; Yin J; Wang S; Ouyang Y; Chen D
    Biomed Res Int; 2019; 2019():8727935. PubMed ID: 30886864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
    Thomson CA; Chow HHS; Wertheim BC; Roe DJ; Stopeck A; Maskarinec G; Altbach M; Chalasani P; Huang C; Strom MB; Galons JP; Thompson PA
    Breast Cancer Res Treat; 2017 Aug; 165(1):97-107. PubMed ID: 28560655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,3'-Diindolylmethane: A Promising Sensitizer of γ-Irradiation.
    Wang W; Lv M; Huangfu C; Wang F; Zhang J
    Biomed Res Int; 2015; 2015():465105. PubMed ID: 26579534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel application of 3,3'-diindolylmethane: sensitizing multidrug resistance human breast cancer cells to γ-irradiation.
    Wang W; Lv M; Wang Y; Zhang J
    Pharm Biol; 2016 Dec; 54(12):3164-3168. PubMed ID: 27307186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization of the apoptotic effect of gamma-irradiation in genistein-pretreated CaSki cervical cancer cells.
    Shin JI; Shim JH; Kim KH; Choi HS; Kim JW; Lee HG; Kim BY; Park SN; Park OJ; Yoon DY
    J Microbiol Biotechnol; 2008 Mar; 18(3):523-31. PubMed ID: 18388472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization by PARP inhibition to proton beam irradiation in cancer cells.
    Hirai T; Saito S; Fujimori H; Matsushita K; Nishio T; Okayasu R; Masutani M
    Biochem Biophys Res Commun; 2016 Sep; 478(1):234-240. PubMed ID: 27425251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitizing effects of gefitinib at different administration times in vitro.
    Zhuang HQ; Sun J; Yuan ZY; Wang J; Zhao LJ; Wang P; Ren XB; Wang CL
    Cancer Sci; 2009 Aug; 100(8):1520-5. PubMed ID: 19432883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin attenuates radioresistance induced by hypoxia in HepG2 cells via the enhancement of PARP1 cleavage and inhibition of JMJD2B.
    Hwang SY; Heo K; Kim JS; Im JW; Lee SM; Cho M; Kang DH; Heo J; Lee JW; Choi CW; Yang K
    Oncol Rep; 2015 Apr; 33(4):1691-8. PubMed ID: 25607726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swainsonine induces apoptosis through mitochondrial pathway and caspase activation in goat trophoblasts.
    Huang Y; Dong F; Du Q; Zhang H; Luo X; Song X; Zhao X; Zhang W; Tong D
    Int J Biol Sci; 2014; 10(7):789-97. PubMed ID: 25076855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe.
    Oike T; Komachi M; Ogiwara H; Amornwichet N; Saitoh Y; Torikai K; Kubo N; Nakano T; Kohno T
    Radiother Oncol; 2014 May; 111(2):222-7. PubMed ID: 24746574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.
    Agoni L; Basu I; Gupta S; Alfieri A; Gambino A; Goldberg GL; Reddy EP; Guha C
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1180-7. PubMed ID: 24529717
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.